ACOR

Acorda Therapeutics
ACOR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

121 hedge funds and large institutions have $106M invested in Acorda Therapeutics in 2019 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 40 increasing their positions, 42 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

68% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 44

Holders
121
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$665K
Puts
$633K
Net Calls
Net Calls Change

Top Buyers

1
+$7.51M
2
+$1.42M
3
+$866K
4
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$857K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$816K

Top Sellers

1
-$7.96M
2
-$6.41M
3
-$2.29M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$1.9M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
151
–
152
–
153
–
154
–
155
–
156
–
157
–
158
–
159
–
160
–
161
–
162
–
3 4 5 6
7